Using a Modified Lymphocyte Genome Sensitivity (LGS) Test or TumorScan Test to Detect Cancer at an Early Stage in Each Individual

Using a Modified Lymphocyte Genome Sensitivity (LGS) Test or TumorScan Test to Detect Cancer at an Early Stage in Each Individual

Yes === Our previous case-control study observed isolated lymphocytes from 208 individuals and determined the differences in the sensitivity to genomic damage of lymphocytes derived from cancer patients, pre/suspect cancer patients and healthy volunteers using the Comet assay (Anderson et al, 2014)....

Full description

Bibliographic Details
Main Authors: Anderson, Diana, Najafzadeh, Mojgan, Scally, Andy J., Jacob, B.K., Griffith, John, Chaha, R., Linforth, R., Soussaline, M., Soussaline, F.
Language:en
Published: 2020
Subjects:
Cancer
Comet assay
Lymphocyte genome sensitivity (LGS)
TumorScan
Online Access:http://hdl.handle.net/10454/17765

Internet

http://hdl.handle.net/10454/17765

Similar Items